Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial (vol 11, pg 193, 2013)

被引：3

作者：

Bailey, Clifford J. ^{[1
]}

Gross, Jorge L. ^{[2
]}

Hennicken, Delphine ^{[3
]}

Iqbal, Nayyar ^{[4
]}

Mansfield, Traci A. ^{[4
]}

List, James F. ^{[4
]}

机构：

[1] Aston Univ, Birmingham B4 7ET, W Midlands, England

[2] Univ Fed Rio Grande do Sul, Div Endocrine, BR-90040060 Porto Alegre, RS, Brazil

[3] Bristol Myers Squibb Co, Global Biometr Serv, B-1420 Braine Ialleud, Belgium

[4] Bristol Myers Squibb Co, Global Clin Res, Princeton, NJ 08543 USA

来源：

关键词：

D O I：

10.1186/1741-7015-11-193

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3